Back
Cellectar Biosciences Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
47
CLRB
Cellectar Biosciences
Last Price:
2.14
Seasonality Move:
-2.36%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLRB is experiencing slight selling pressure.
Cellectar Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.07 | Buy |
| 20-day SMA: | 2.07 | Buy |
| 50-day SMA: | 2.08 | Buy |
| 200-day SMA: | 2.83 | Sell |
| 8-day EMA: | 2.09 | Buy |
| 20-day EMA: | 2.08 | Buy |
| 50-day EMA: | 2.11 | Buy |
| 200-day EMA: | 2.49 | Sell |
Cellectar Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 57.1 | Buy |
| Chaikin Money Flow: | -38099 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.04 - 2.12) | Buy |
| Bollinger Bands (100): | (1.96 - 2.44) | Sell |
Cellectar Biosciences Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cellectar Biosciences Stock
Is Cellectar Biosciences Stock a Buy?
- Cellectar Biosciences share price is 2.13 while CLRB 8-day simple moving average is 2.07, which is a Buy signal.
- The stock price of CLRB is 2.13 while Cellectar Biosciences 20-day SMA is 2.07, which makes it a Buy.
- Cellectar Biosciences 50-day simple moving average is 2.08 while CLRB share price is 2.13, making it a Buy technically.
- CLRB stock price is 2.13 and Cellectar Biosciences 200-day simple moving average is 2.83, creating a Sell signal.
CLRB Technical Analysis vs Fundamental Analysis
Sell
47
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a Sell
The current Cellectar Biosciences [CLRB] share price is $2.13. The Score for CLRB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Cellectar Biosciences Stock Info
Market Cap:
86.41M
Price in USD:
2.13
Share Volume:
317.49K
Cellectar Biosciences 52-Week Range
52-Week High:
4.45
52-Week Low:
1.82
Sell
47
Cellectar Biosciences (CLRB)
is a Sell
Cellectar Biosciences Share Price Forecast
-
What is the Cellectar Biosciences stock price today?
The Cellectar Biosciences stock price is 2.13 USD today. -
Will CLRB stock go up or go down?
Cellectar Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Cellectar Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cellectar Biosciences is overvalued.
Is Cellectar Biosciences Stock a Buy?
- Cellectar Biosciences share price is 2.13 while CLRB 8-day exponential moving average is 2.09, which is a Buy signal.
- The stock price of CLRB is 2.13 while Cellectar Biosciences 20-day EMA is 2.08, which makes it a Buy.
- Cellectar Biosciences 50-day exponential moving average is 2.11 while CLRB share price is 2.13, making it a Buy technically.
- CLRB stock price is 2.13 and Cellectar Biosciences 200-day simple moving average is 2.49, creating a Sell signal.
Fundamental Analysis of Cellectar Biosciences
Is Cellectar Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.
Technical Analysis of Cellectar Biosciences
Should I short Cellectar Biosciences stock?
- CLRB Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Cellectar Biosciences is a Buy
- Cellectar Biosciences Relative Strength Index (RSI) is 57.1, which suggest Cellectar Biosciences is overbought
- The Bollinger Bands (25) for Cellectar Biosciences is (2.04 - 2.12), which suggest Cellectar Biosciences is a Sell
- The Bollinger Bands (100) for Cellectar Biosciences is (1.96 - 2.44), which suggest Cellectar Biosciences is a Sell
* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.